1. Home
  2. TWIN vs GBIO Comparison

TWIN vs GBIO Comparison

Compare TWIN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWIN
  • GBIO
  • Stock Information
  • Founded
  • TWIN 1918
  • GBIO 2016
  • Country
  • TWIN United States
  • GBIO United States
  • Employees
  • TWIN N/A
  • GBIO N/A
  • Industry
  • TWIN Industrial Machinery/Components
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWIN Industrials
  • GBIO Health Care
  • Exchange
  • TWIN Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • TWIN 97.0M
  • GBIO 29.2M
  • IPO Year
  • TWIN N/A
  • GBIO 2020
  • Fundamental
  • Price
  • TWIN $9.41
  • GBIO $0.39
  • Analyst Decision
  • TWIN Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • TWIN 1
  • GBIO 4
  • Target Price
  • TWIN $12.00
  • GBIO $7.33
  • AVG Volume (30 Days)
  • TWIN 153.9K
  • GBIO 1.1M
  • Earning Date
  • TWIN 08-14-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • TWIN 1.71%
  • GBIO N/A
  • EPS Growth
  • TWIN N/A
  • GBIO N/A
  • EPS
  • TWIN 0.29
  • GBIO N/A
  • Revenue
  • TWIN $328,478,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • TWIN $27.91
  • GBIO N/A
  • Revenue Next Year
  • TWIN N/A
  • GBIO N/A
  • P/E Ratio
  • TWIN $32.10
  • GBIO N/A
  • Revenue Growth
  • TWIN 11.49
  • GBIO 146.47
  • 52 Week Low
  • TWIN $6.16
  • GBIO $0.30
  • 52 Week High
  • TWIN $14.98
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • TWIN 62.89
  • GBIO 52.02
  • Support Level
  • TWIN $9.19
  • GBIO $0.32
  • Resistance Level
  • TWIN $9.77
  • GBIO $0.36
  • Average True Range (ATR)
  • TWIN 0.51
  • GBIO 0.03
  • MACD
  • TWIN 0.02
  • GBIO 0.00
  • Stochastic Oscillator
  • TWIN 70.33
  • GBIO 81.00

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: